Davis Selected Advisers Cuts Stake in Humana Inc. (NYSE:HUM)

Davis Selected Advisers lessened its position in shares of Humana Inc. (NYSE:HUM – Get Rating) by 0.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,436 shares of the insurance provider’s stock after selling 65 shares during the quarter. Davis Selected Advisers’ holdings in Humana were worth $22,247,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. Thrivent Financial for Lutherans lifted its stake in Humana by 0.8% in the fourth quarter. Thrivent Financial for Lutherans now owns 7,465 shares of the insurance provider’s stock worth $3,824,000 after acquiring an additional 58 shares during the period. Atlas Capital Advisors LLC grew its stake in shares of Humana by 546.3% during the 3rd quarter. Atlas Capital Advisors LLC now owns 614 shares of the insurance provider’s stock worth $298,000 after purchasing an additional 519 shares during the period. Robeco Institutional Asset Management B.V. grew its stake in shares of Humana by 129.6% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 137,224 shares of the insurance provider’s stock worth $70,285,000 after purchasing an additional 77,464 shares during the period. Gateway Investment Advisers LLC grew its stake in shares of Humana by 14.9% during the 4th quarter. Gateway Investment Advisers LLC now owns 608 shares of the insurance provider’s stock worth $311,000 after purchasing an additional 79 shares during the period. Finally, Simplicity Solutions LLC grew its stake in shares of Humana by 15.4% during the 4th quarter. Simplicity Solutions LLC now owns 1,205 shares of the insurance provider’s stock worth $617,000 after purchasing an additional 161 shares during the period. Hedge funds and other institutional investors own 93.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on HUM shares. Truist Financial raised their price objective on Humana from $560.00 to $590.00 and gave the company a “hold” rating in a report on Thursday, April 13th. TheStreet raised Humana from a “c+” rating to a “b-” rating in a research report on Thursday, April 13th. StockNews.com started coverage on Humana in a research report on Thursday, May 18th. They set a “strong-buy” rating for the company. Morgan Stanley lifted their target price on Humana from $620.00 to $637.00 and gave the company an “overweight” rating in a research report on Tuesday, April 11th. Finally, Cowen decreased their price objective on Humana from $647.00 to $581.00 and set an “outperform” rating for the company in a research note on Monday, February 6th. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Humana presently has an average rating of “Moderate Buy” and a consensus target price of $597.37.

Humana Trading Down 0.7 %

Shares of Humana stock traded down $3.59 on Friday, reaching $496.48. 311,366 shares of the company were exchanged, compared to its average volume of 977,178. The stock has a fifty day moving average price of $513.05 and a 200-day moving average price of $510.77. The firm has a market capitalization of $62.03 billion, a price-to-earnings ratio of 20.31, a price-to-earnings-growth ratio of 1.32 and a beta of 0.72. The company has a current ratio of 1.39, a quick ratio of 1.39 and a debt-to-equity ratio of 0.59. Humana Inc. has a fifty-two week low of $418.70 and a fifty-two week high of $571.30.

Humana (NYSE:HUM – Get Rating) last posted its quarterly earnings results on Wednesday, April 26th. The insurance provider reported $9.38 earnings per share for the quarter, beating the consensus estimate of $9.25 by $0.13. The firm had revenue of $26.74 billion for the quarter, compared to analyst estimates of $26.40 billion. Humana had a return on equity of 21.04% and a net margin of 3.26%. Humana’s quarterly revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the firm earned $8.04 earnings per share. On average, analysts expect that Humana Inc. will post 28.28 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 28th. Stockholders of record on Friday, June 30th will be paid a dividend of $0.885 per share. The ex-dividend date is Thursday, June 29th. This represents a $3.54 annualized dividend and a dividend yield of 0.71%. Humana’s dividend payout ratio (DPR) is presently 14.38%.

Insider Transactions at Humana

In related news, CFO Susan M. Diamond sold 4,156 shares of the stock in a transaction that occurred on Thursday, May 4th. The stock was sold at an average price of $526.28, for a total transaction of $2,187,219.68. Following the completion of the sale, the chief financial officer now owns 3,931 shares in the company, valued at approximately $2,068,806.68. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other Humana news, CEO Bruce D. Broussard sold 17,575 shares of the company’s stock in a transaction that occurred on Monday, February 27th. The stock was sold at an average price of $505.85, for a total value of $8,890,313.75. Following the completion of the transaction, the chief executive officer now owns 70,040 shares of the company’s stock, valued at approximately $35,429,734. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Susan M. Diamond sold 4,156 shares of the stock in a transaction that occurred on Thursday, May 4th. The stock was sold at an average price of $526.28, for a total value of $2,187,219.68. Following the completion of the transaction, the chief financial officer now directly owns 3,931 shares of the company’s stock, valued at $2,068,806.68. The disclosure for this sale can be found here. In the last quarter, insiders sold 23,779 shares of company stock worth $12,117,856. 0.32% of the stock is owned by corporate insiders.

Humana Profile

(Get Rating)

Humana Inc engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts.